Novo Nordisk A/S’s Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient Option

PRINCETON, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Today Novo Nordisk announced the availability of the Norditropin (somatropin [rDNA origin] injection) NordiFlex(®) 30 mg/3 mL, the only prefilled, preloaded pen that allows children who need a dose of growth hormone larger than 4.5 mg to take one injection instead of two. The pen holds twice the volume of, and has a higher maximum dose than, the 15 mg Norditropin NordiFlex(®) pen, offering a more convenient option for patients who require a growth hormone dose up to 6.0 mg.